|
Pfizer and AstraZeneca enter into agreement for over-the-counter Nexium
|
13 August 2012 |
|
Pfizer reports second-quarter 2012 results
|
31 July 2012 |
|
Pfizer reports top-line results of study of Lyrica's effect on male reproduction
|
23 July 2012 |
|
Pfizer provides topline results from Phase 3 study of Torisel®
|
16 May 2012 |
|
Pfizer reports first-quarter 2012 results
|
01 May 2012 |
|
Pfizer's Prevnar 13® shown to be immunogenic in older children and adolescents
|
12 March 2012 |
|
Pfizer acquires Alacer Corp., a leading vitamin supplements company
|
28 February 2012 |
|
Pfizer and Hisun announce progress on potential joint venture
|
20 February 2012 |
|
Pfizer reports fourth-quarter and full-year 2011 results
|
31 January 2012 |
|
Alzheimer's Challenge 2012: seeking new tools to help improve Alzheimer's care
|
29 January 2012 |
|
Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon
|
17 January 2012 |
|
A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health
|
10 January 2012 |
|
Pfizer Receives FDA Approval to Extend Use of Prevnar 13®
|
01 January 2012 |
|
Prevent Pneumococcal Disease in Infants and Young Children in the World's Poorest Countries
|
18 December 2011 |
|
Pfizer Elects CEO Ian Read as Chairman of the Board
|
12 December 2011 |
|
Pfizer Completes Acquisition of Excaliard
|
04 December 2011 |
|
Pfizer to Acquire Excaliard Pharmaceuticals
|
22 November 2011 |
|
Pfizer Wins Corporate Citizenship Award For Global Health Partnerships Program
|
20 November 2011 |
|
Treatment with Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits
|
07 November 2011 |
|
Pfizer Reports Third-Quarter 2011 Results
|
01 November 2011 |